• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重社区获得性医疗保健相关艰难梭菌感染,合并产碳青霉烯酶肺炎克雷伯菌血流感染。

Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.

作者信息

Giuliano Simone, Guastalegname Maurizio, Jenco Miryam, Morelli Andrea, Falcone Marco, Venditti Mario

机构信息

Department of Public Health and Infectious Diseases Policlinico Umberto I, "Sapienza" University of Rome, Viale del Policlinico 155, 00161 Rome, Italy.

出版信息

BMC Infect Dis. 2014 Sep 1;14:475. doi: 10.1186/1471-2334-14-475.

DOI:10.1186/1471-2334-14-475
PMID:25178451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4161886/
Abstract

BACKGROUND

Clostridium difficile infection (CDI) and Klebsiella pneumoniae carbapenemase producing-Klebsiella pneumoniae (KPC-Kp) bloodstream infection (BSI) are emerging health-care associated (HCA) diseases of public health concern, in terms of morbidity, mortality, and insufficient response to antibiotic therapy. Both agents can be acquired in the hospital but clinical disease can develop in a community setting, after discharge. We report here a putative link between the above-mentioned healthcare associated infections that appeared as a dramatic community onset disease with a fulminant fatal outcome.

CASE PRESENTATION

We describe the case of a 63 year old man affected by severe CDI. Even though the patient underwent 72 hours of standard CDI antibiotic treatment, the clinical course was complicated by toxic megacolon and KPC-Kp BSI. The patient died 24 hours after total colectomy.

CONCLUSION

The impact of HCA-BSIs in complicating CDI is still unknown. Intestinal inflammatory injury and disruption of intestinal flora by standard antibiotic treatment could be responsible for promoting difficult-to-treat infections in CDI. By preserving intestinal flora, Fidaxomicin could have a crucial role in preventing BSIs complicating severe CDI.

摘要

背景

艰难梭菌感染(CDI)和产肺炎克雷伯菌碳青霉烯酶的肺炎克雷伯菌(KPC-Kp)血流感染(BSI)是新出现的与医疗保健相关(HCA)的疾病,在发病率、死亡率以及对抗生素治疗反应不足方面引发了公共卫生关注。这两种病原体都可在医院获得,但临床疾病也可能在出院后的社区环境中发生。我们在此报告上述与医疗保健相关感染之间的一种假定联系,该感染表现为一种具有暴发性致命结局的严重社区发病疾病。

病例报告

我们描述了一名63岁患有严重CDI的男性病例。尽管患者接受了72小时的标准CDI抗生素治疗,但临床病程因中毒性巨结肠和KPC-Kp BSI而复杂化。患者在全结肠切除术后24小时死亡。

结论

HCA-BSIs在使CDI复杂化方面的影响仍不清楚。标准抗生素治疗导致的肠道炎性损伤和肠道菌群破坏可能是促使CDI中出现难以治疗的感染的原因。通过保护肠道菌群,非达霉素在预防BSIs使严重CDI复杂化方面可能具有关键作用。

相似文献

1
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.严重社区获得性医疗保健相关艰难梭菌感染,合并产碳青霉烯酶肺炎克雷伯菌血流感染。
BMC Infect Dis. 2014 Sep 1;14:475. doi: 10.1186/1471-2334-14-475.
2
Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.血流感染中 CP-Kp、ESBL-E、念珠菌和 CDI 的流行病学和死亡风险因素:一项单中心回顾性研究。
Eur J Intern Med. 2018 Feb;48:44-49. doi: 10.1016/j.ejim.2017.10.015. Epub 2017 Oct 31.
3
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.希腊重症监护病房患者中产金属β-内酰胺酶/肺炎克雷伯菌碳青霉烯酶的肺炎克雷伯菌引起的血流感染:感染的危险因素和耐药类型对结局的影响。
Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25.
4
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.重症监护病房中产KPC肺炎克雷伯菌血流感染患者的感染危险因素及死亡预测因素。
Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14.
5
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.艰难梭菌感染继发血流感染的危险因素及结局
Antimicrob Agents Chemother. 2015 Oct 19;60(1):252-7. doi: 10.1128/AAC.01927-15. Print 2016 Jan.
6
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.及时应用抗生素治疗是产 KPC 肺炎克雷伯菌血流感染患者预后的预测因素。
Crit Care. 2020 Jan 30;24(1):29. doi: 10.1186/s13054-020-2742-9.
7
Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.高毒力肺炎克雷伯菌引起的血流感染的危险因素和临床结局。
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):679-689. doi: 10.1007/s10096-017-3160-z. Epub 2017 Dec 14.
8
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.产碳青霉烯酶肺炎克雷伯菌血流感染患者的死亡预测因素及恰当抗菌治疗的影响。
Clin Microbiol Infect. 2011 Dec;17(12):1798-803. doi: 10.1111/j.1469-0691.2011.03514.x. Epub 2011 May 20.
9
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.癌症患者感染产肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌。
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):277-86. doi: 10.1007/s10096-014-2233-5. Epub 2014 Aug 30.
10
Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections.产 KPC 碳青霉烯酶肺炎克雷伯菌感染所致死亡率:系统评价和荟萃分析:产 KPC 肺炎克雷伯菌感染所致死亡率。
J Infect. 2018 May;76(5):438-448. doi: 10.1016/j.jinf.2018.02.007. Epub 2018 Mar 1.

引用本文的文献

1
Bacterial metabolites influence the autofluorescence of .细菌代谢产物会影响……的自发荧光。 (原文此处不完整)
Front Microbiol. 2024 Oct 8;15:1459795. doi: 10.3389/fmicb.2024.1459795. eCollection 2024.
2
Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Infection.感染期间持续存在的全身微生物易位、炎症和肠道损伤。
Open Forum Infect Dis. 2019 Dec 3;7(1):ofz507. doi: 10.1093/ofid/ofz507. eCollection 2020 Jan.
3
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.艰难梭菌感染继发血流感染的危险因素及结局
Antimicrob Agents Chemother. 2015 Oct 19;60(1):252-7. doi: 10.1128/AAC.01927-15. Print 2016 Jan.

本文引用的文献

1
Clostridium difficile 027 increasing detection in a teaching hospital in Rome, Italy.艰难梭菌027在意大利罗马一家教学医院的检出率不断上升。
Infection. 2014 Oct;42(5):941-2. doi: 10.1007/s15010-014-0652-y. Epub 2014 Jul 11.
2
Healthcare-associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: the time has come.医疗保健相关产碳青霉烯酶肺炎克雷伯菌所致的肺炎克雷伯菌血流感染:时机已至。
Clin Infect Dis. 2014 Jul 15;59(2):321-2. doi: 10.1093/cid/ciu294. Epub 2014 Apr 24.
3
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy.意大利一家重症监护病房内爆发的艰难梭菌性暴发性结肠炎。
Infection. 2014 Jun;42(3):585-9. doi: 10.1007/s15010-014-0597-1. Epub 2014 Feb 13.
4
Candidemia subsequent to severe infection due to Clostridium difficile: is there a link?艰难梭菌严重感染后继发念珠菌血症:存在关联吗?
Clin Infect Dis. 2013 Sep;57(5):772-4. doi: 10.1093/cid/cit362. Epub 2013 May 30.
5
Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.意大利城市医院的艰难梭菌感染:2006 年至 2011 年的数据。
BMC Infect Dis. 2013 Mar 22;13:146. doi: 10.1186/1471-2334-13-146.
6
Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.细菌穿透了正常情况下无法穿透的两种结肠炎模型中的肠道内层黏液层和溃疡性结肠炎患者的肠道内层黏液层。
Gut. 2014 Feb;63(2):281-91. doi: 10.1136/gutjnl-2012-303207. Epub 2013 Feb 20.
7
Clostridium difficile 027 infection in Central Italy.意大利中部艰难梭菌 027 感染。
BMC Infect Dis. 2012 Dec 22;12:370. doi: 10.1186/1471-2334-12-370.
8
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.碳青霉烯类耐药肺炎克雷伯菌感染患者中,多粘菌素耐药率高导致死亡率过高。
Clin Microbiol Infect. 2013 Jan;19(1):E23-E30. doi: 10.1111/1469-0691.12070. Epub 2012 Nov 9.
9
KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units.2009 年 6 月至 2011 年 12 月意大利帕多瓦两所医院中的肺炎克雷伯菌中产 KPC 酶耐药:一种携带 KPC-3 基因的质粒的广泛传播及非重症监护病房的参与
Gut Pathog. 2012 Jul 16;4(1):7. doi: 10.1186/1757-4749-4-7.
10
Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. fidaxomicin 在治疗艰难梭菌感染 (CDI) 期间和之后保留肠道微生物组,并减少毒素再表达和 CDI 的复发。
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S132-42. doi: 10.1093/cid/cis338.